5-year survival of high-risk patients after EBRT + brachytherapy

Long-term data on survival of high-risk patients after treatment with a combination of external beam radiation therapy (EBRT) and brachytherapy (radioactive seed implantation), with or without neoadjuvant and adjuvant androgen deprivation therapy (ADT), are not well established as yet. … READ MORE …